Sagimet Biosciences Inc.
SGMTHealthcare|Biotechnology|US
$9.85
+0.73 (+8.00%)
DCF Value
$1.05
Tangible Book / Share
$4.82
Cash / Share
$4.52
Ownership Breakdown
95.8%
Float
32.6M
Shares Outstanding
31.2M
Float Shares
Major Holders (19)
Combined: 109.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | Holding company | 7.80% | 4,751,186 | Jul 30, 2026 | 13D/G |
| Commodore Capital LP | IA, PN | 7.60% | 5,507,752 | Oct 7, 2026 | 13D/G |
| Commodore Capital Master LP | Partnership | 7.60% | 5,507,752 | Oct 7, 2026 | 13D/G |
| Robert Egen Atkinson | HC, IN | 7.60% | 5,507,752 | Oct 7, 2026 | 13D/G |
| Michael Kramarz | HC, IN | 7.60% | 5,507,752 | Oct 7, 2026 | 13D/G |
| Dmitry Balyasny | HC, IN | 5.93% | 3,626,113 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management Holdings LP | HC, PN | 5.93% | 3,626,113 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management L.P. | IA, PN | 5.93% | 3,626,113 | Aug 14, 2026 | 13D/G |
| Bam GP LLC | HC, OO | 5.93% | 3,626,113 | Aug 14, 2026 | 13D/G |
| Dames GP LLC | HC, OO | 5.93% | 3,626,113 | Aug 14, 2026 | 13D/G |
| Baker Bros. Advisors LP | IA, PN | 4.99% | 1,538,489 | Nov 14, 2024 | 13D/G |
| Baker Bros. Advisors (GP) LLC | HC, OO | 4.99% | 1,538,489 | Nov 14, 2024 | 13D/G |
| Felix J. Baker | HC, IN | 4.99% | 1,538,489 | Nov 14, 2024 | 13D/G |
| Julian C. Baker | HC, IN | 4.99% | 1,538,489 | Nov 14, 2024 | 13D/G |
| AP11 Limited | FI, CO | 4.90% | 1,504,642 | Jun 24, 2025 | 13D/G |
| Ascletis Pharma Inc. | FI, CO | 4.90% | 1,504,642 | Jun 24, 2025 | 13D/G |
| Woodline Partners LP | IA, PN | 4.80% | 1,501,357 | Nov 14, 2025 | 13D/G |
| Blue Owl Capital Holdings LP | Partnership | 4.32% | 1,323,877 | Feb 14, 2025 | 13D/G |
| Hillhouse Investment Management, Ltd. | Investment adviser | 2.40% | 724,800 | Nov 14, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,810,589 acquired · 191,215 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kemble George | director | Aug 14, 2026 | OPTION EX. | 24,369 | $6.36 | $155.0K | Form 4 |
| Kemble George | director | Aug 14, 2026 | OPTION EX. | 326,618 | $6.36 | $2.1M | Form 4 |
| Kemble George | director | Aug 14, 2026 | SELL | 350,987 | $10.23 | $3.6M | Form 4 |
| Kemble George | director | Aug 14, 2026 | OPTION EX. | 326,618 | $6.36 | $2.1M | Form 4 |
| Kemble George | director | Aug 14, 2026 | OPTION EX. | 24,369 | $6.36 | $155.0K | Form 4 |
| Kemble George | director | Aug 11, 2026 | OPTION EX. | 9,751 | $6.36 | $62.0K | Form 4 |
| Kemble George | director | Aug 11, 2026 | OPTION EX. | 10,455 | $6.36 | $66.5K | Form 4 |
| Kemble George | director | Aug 11, 2026 | OPTION EX. | 9,751 | $6.36 | $62.0K | Form 4 |
| Kemble George | director | Aug 11, 2026 | SELL | 20,206 | $9.95 | $201.1K | Form 4 |
| Kemble George | director | Aug 11, 2026 | OPTION EX. | 10,455 | $6.36 | $66.5K | Form 4 |
| Happel David | director, officer: President & CEO | Jul 20, 2026 | SELL | 64,051 | $7.76 | $497.1K | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Jul 20, 2026 | SELL | 10,545 | $7.76 | $81.8K | Form 4 |
| Kemble George | director | Jul 20, 2026 | SELL | 18,844 | $7.46 | $140.5K | Form 4 |
| SEIDENBERG BETH C | director | Jun 12, 2026 | AWARD | 39,567 | $6.48 | $256.4K | Form 4 |
| Hoelscher Paul W. | director | Jun 12, 2026 | AWARD | 39,567 | $6.48 | $256.4K | Form 4 |
| Jarrett Jennifer | director | Jun 12, 2026 | AWARD | 39,567 | $6.48 | $256.4K | Form 4 |
| GRAMMER ELIZABETH A | director | Jun 12, 2026 | AWARD | 39,567 | $6.48 | $256.4K | Form 4 |
| Kemble George | director | Jun 12, 2026 | AWARD | 39,567 | $6.48 | $256.4K | Form 4 |
| Phillips Anne M. | director | Jun 12, 2026 | AWARD | 39,567 | $6.48 | $256.4K | Form 4 |
| Chauche Thierry | Chief Financial Officer | May 28, 2026 | AWARD | 50,000 | $7.27 | $363.5K | Form 4 |
| Grauer Andreas | Chief Medical Officer | May 28, 2026 | AWARD | 35,000 | $7.27 | $254.4K | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | May 28, 2026 | AWARD | 100,000 | $7.27 | $727.0K | Form 4 |
| Happel David | director, officer: President & CEO | May 28, 2026 | AWARD | 300,000 | $7.27 | $2.2M | Form 4 |
| Grauer Andreas | Chief Medical Officer | Apr 20, 2026 | AWARD | 264,759 | $6.44 | $1.7M | Form 4 |
| Grauer Andreas | officer | Apr 20, 2026 | OTHER | 0 | — | — | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Feb 19, 2026 | AWARD | 44,000 | — | — | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Feb 19, 2026 | AWARD | 88,000 | $5.38 | $473.4K | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Feb 19, 2026 | AWARD | 44,000 | — | — | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Feb 19, 2026 | AWARD | 88,000 | $5.38 | $473.4K | Form 4 |
| Happel David | director, officer: President & CEO | Feb 19, 2026 | AWARD | 128,000 | — | — | Form 4 |
| Happel David | director, officer: President & CEO | Feb 19, 2026 | AWARD | 256,000 | $5.38 | $1.4M | Form 4 |
| Chauche Thierry | Chief Financial Officer | Feb 19, 2026 | AWARD | 88,000 | $5.38 | $473.4K | Form 4 |
| Chauche Thierry | Chief Financial Officer | Feb 19, 2026 | AWARD | 44,000 | — | — | Form 4 |
| Happel David | director, officer: President & CEO | Feb 10, 2026 | SELL | 12,101 | $5.36 | $64.9K | Form 4 |
| Chauche Thierry | Chief Financial Officer | Feb 10, 2026 | SELL | 1,312 | $5.36 | $7.0K | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Feb 10, 2026 | SELL | 3,640 | $5.36 | $19.5K | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Feb 10, 2026 | SELL | 2,622 | $5.36 | $14.1K | Form 4 |
| Kemble George | director, officer: Executive Chairman | Nov 20, 2025 | SELL | 37,688 | $7.69 | $290.0K | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Nov 4, 2025 | AWARD | 9,855 | — | — | Form 4 |
| Rozek Elizabeth | Chief Legal & Admin. Officer | Nov 4, 2025 | AWARD | 13,367 | $7.61 | $101.7K | Form 4 |
| Happel David | director, officer: President & CEO | Jul 21, 2025 | SELL | 65,478 | $9.13 | $598.1K | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Jul 21, 2025 | SELL | 8,277 | $9.13 | $75.6K | Form 4 |
| Rozek Elizabeth | General Counsel and CCO | Jul 21, 2025 | SELL | 10,780 | $9.13 | $98.5K | Form 4 |
| Walbert Timothy P | director | Jun 9, 2025 | AWARD | 32,250 | $5.33 | $171.9K | Form 4 |
| SEIDENBERG BETH C | director | Jun 9, 2025 | AWARD | 32,250 | $5.33 | $171.9K | Form 4 |
| SEIDENBERG BETH C | director | Jun 6, 2025 | AWARD | 28,522 | $5.56 | $158.6K | Form 4 |
| Phillips Anne M. | director | Jun 9, 2025 | AWARD | 27,268 | $5.33 | $145.3K | Form 4 |
| Kemble George | director | Jun 9, 2025 | AWARD | 32,250 | $5.33 | $171.9K | Form 4 |
| Jarrett Jennifer | director | Jun 9, 2025 | AWARD | 27,268 | $5.33 | $145.3K | Form 4 |
| Hoelscher Paul W. | director | Jun 9, 2025 | AWARD | 32,250 | $5.33 | $171.9K | Form 4 |
| GRAMMER ELIZABETH A | director | Jun 9, 2025 | AWARD | 32,250 | $5.33 | $171.9K | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Feb 6, 2025 | AWARD | 138,000 | $4.71 | $650.0K | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Feb 6, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Happel David | director, officer: President & CEO | Feb 6, 2025 | AWARD | 116,000 | — | — | Form 4 |
| Happel David | director, officer: President & CEO | Feb 6, 2025 | AWARD | 472,000 | $4.71 | $2.2M | Form 4 |
| Rozek Elizabeth | General Counsel and CCO | Feb 6, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Rozek Elizabeth | General Counsel and CCO | Feb 6, 2025 | AWARD | 138,000 | $4.71 | $650.0K | Form 4 |
| Chauche Thierry | Chief Financial Officer | Feb 6, 2025 | AWARD | 69,000 | $4.71 | $325.0K | Form 4 |
| Chauche Thierry | Chief Financial Officer | Feb 6, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Jarrett Jennifer | director | Aug 1, 2024 | AWARD | 113,895 | $3.48 | $396.4K | Form 4 |
| Phillips Anne M. | director | Aug 1, 2024 | AWARD | 113,895 | $3.48 | $396.4K | Form 4 |
| Jarrett Jennifer | director: | Aug 1, 2024 | OTHER | 0 | — | — | Form 4 |
| Phillips Anne M. | director: | Aug 1, 2024 | OTHER | 0 | — | — | Form 4 |
| Kemble George | director, officer: Executive Chairman | Jul 23, 2024 | SELL | 23,625 | $3.17 | $74.8K | Form 4 |
| Martins Eduardo Bruno | Chief Medical Officer | Jul 19, 2024 | SELL | 8,357 | $3.10 | $25.9K | Form 4 |
| Rozek Elizabeth | General Counsel and CCO | Jul 19, 2024 | SELL | 10,914 | $3.10 | $33.8K | Form 4 |
| Kemble George | director, officer: Executive Chairman | Jul 19, 2024 | SELL | 14,062 | $3.10 | $43.6K | Form 4 |
| Walbert Timothy P | director | Jun 5, 2024 | AWARD | 9,279 | $4.64 | $43.1K | Form 4 |
| SEIDENBERG BETH C | director | Jun 5, 2024 | AWARD | 51,459 | $4.64 | $238.8K | Form 4 |
| Parsey Merdad | director | Jun 5, 2024 | AWARD | 51,459 | $4.64 | $238.8K | Form 4 |
| Hoelscher Paul W. | director | Jun 5, 2024 | AWARD | 9,279 | $4.64 | $43.1K | Form 4 |
| GRAMMER ELIZABETH A | director | Jun 5, 2024 | AWARD | 51,459 | $4.64 | $238.8K | Form 4 |
| Chauche Thierry | Chief Financial Officer | May 6, 2024 | AWARD | 587,181 | $4.28 | $2.5M | Form 4 |
| Chauche Thierry | officer | May 6, 2024 | OTHER | 0 | — | — | Form 4 |
| Walbert Timothy P | director | Apr 1, 2024 | AWARD | 73,014 | $5.23 | $381.9K | Form 4 |
| Hoelscher Paul W. | director | Apr 1, 2024 | AWARD | 73,014 | $5.23 | $381.9K | Form 4 |
| Walbert Timothy P | director | Apr 1, 2024 | DISPOSED | 0 | — | — | Form 4 |
| Hoelscher Paul W. | director: | Apr 1, 2024 | OTHER | 0 | — | — | Form 4 |
| Happel David | director, officer: President & CEO | Mar 26, 2024 | BUY | 12,100 | $5.27 | $63.7K | Form 4 |
| SANDELL SCOTT D | 10 percent owner | Jan 29, 2024 | DISPOSED | 850,000 | — | — | Form 4 |
| SANDELL SCOTT D | 10 percent owner | Jan 29, 2024 | J | 260,950 | — | — | Form 4 |
| SANDELL SCOTT D | 10 percent owner | Jan 29, 2024 | J | 6,997 | — | — | Form 4 |
| SANDELL SCOTT D | 10 percent owner | Jan 29, 2024 | DISPOSED | 260,950 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jan 29, 2024 | DISPOSED | 850,000 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | BUY | 30,000 | $16.00 | $480.0K | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | X | 13,404 | $0.79 | $10.7K | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | SELL | 662 | $16.00 | $10.6K | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 3,769,857 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | J | 37,676 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 11,363,635 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | DISPOSED | 37,676 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 23,041,474 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 14,659,091 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 11,363,634 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | DISPOSED | 13,404 | $0.79 | $10.7K | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 237,893,958 | — | — | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 18, 2023 | CONVERSION | 1,301,130 | — | — | Form 4 |
| GRAMMER ELIZABETH A | director | Jul 18, 2023 | AWARD | 49,533 | $8.74 | $432.9K | Form 4 |
| GRAMMER ELIZABETH A | director | Jul 18, 2023 | DISPOSED | 49,533 | $8.74 | $432.9K | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | Jul 13, 2023 | DISPOSED | 0 | — | — | Form 4 |